Gentian Diagnostics AS Capital Reinvestment Ratio
Gentian Diagnostics AS capital reinvestment ratio. Gentian Diagnostics AS (GENT) has a Capital Reinvestment Ratio of 0.25x as of December 2025, meaning it reinvests 0% of its operating cash flow (Nkr42.59 Million) in capital expenditures (Nkr10.76 Million). Check how aggressively does Gentian Diagnostics AS reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Gentian Diagnostics AS (2013–2025)
Capital reinvestment ratio of Gentian Diagnostics AS from 2013 to 2025. This chart tracks Gentian Diagnostics AS's Capital Reinvestment Ratio across 4 annual periods. Also explore GENT year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Gentian Diagnostics AS Capital Reinvestment Ratio by Year (2013–2025)
Gentian Diagnostics AS capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see Gentian Diagnostics AS (GENT) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | Nkr42.59 Million | Nkr10.76 Million | ▼ -69.0% |
| 2024 | 0.81x | Nkr13.46 Million | Nkr10.95 Million | ▲ +180.3% |
| 2023 | 0.29x | Nkr15.46 Million | Nkr4.49 Million | ▼ -79.8% |
| 2013 | 1.44x | Nkr2.43 Million | Nkr3.49 Million | — |